The new edition of this successful book specifically designed for families of patients with Huntington's disease has been expanded to include a number of important new developments in research and clinical practice that have occurred in the field in recent years. While there are no drugs currently available that slow down or reverse the neurodegenerative process in Huntington's disease, there is growing data on the use of existing treatments to manage movement
disorder, irritability and depression associated with the condition, which will be expanded on here. This edition will also include completely new chapters covering juvenile Huntington's disease and late-stage Huntington's disease. The book will also include a fully updated Appendix of relevant
Dr Oliver Quarrell has been elected to the Executive Council of the Huntington's Disease Association and currently serves as its vice Chairman. He is also actively involved in the European Huntington's Disease Network.